Thursday, 23 Jul, 2026

Medical Milestone: Japan Approves Public Insurance Coverage for Landmark iPS-Derived Heart Treatment

In a transformative development for regenerative medicine, Japan’s Central Social Insurance Medical Council officially granted public health insurance coverage to "RiHeart," an innovative cardiac muscle cell sheet derived from induced pluripotent stem (iPS) cells. The approval, finalized this Wednesday, marks a historic pivot in how the nation treats severe heart failure, signaling a new era […]